Rallis India Q1 net profit rises 31% to ₹125 crore
Rallis India's Q1FY27 net profit rose 31% to ₹125 crore on ₹1,022 crore revenue, with EBITDA up 23% to ₹184 crore. Growth was led by Crop Care and Seeds segments, offsetting export declines and monsoon delays through strategic pricing and digital engagement.

*this image is generated using AI for illustrative purposes only.
Rallis India Limited reported a 31% rise in net profit to ₹125 crore for the quarter ended June 30, 2026, compared to ₹95 crore in the corresponding period of the previous year. The company’s revenue from operations increased 7% to ₹1,022 crore from ₹957 crore in Q1FY26, driven by a combination of 5% pricing growth and 2% volume expansion. EBITDA for the quarter grew 23% year-on-year to ₹184 crore, with the EBITDA margin expanding to 18% from 15.67%. This performance underscores the company’s ability to maintain profitability despite a challenging macroeconomic environment characterized by delayed monsoons and raw material volatility.
The Board of Directors approved the unaudited financial results for Q1FY27 at a meeting held on July 20, 2026. Statutory auditors BSR & Co. LLP expressed an unmodified review conclusion on the results. Total income for the quarter stood at ₹1,035 crore, up from ₹969 crore in Q1FY26. Total expenses rose to ₹869 crore from ₹840 crore, while the cost of materials consumed increased to ₹618 crore from ₹473 crore. Profit before tax improved to ₹168 crore from ₹129 crore, supported by operational efficiencies and strategic pricing actions across key segments.
Financial Performance Summary
The table below presents the key financial metrics for Q1FY27 against Q1FY26:
| Particulars: | Q1FY27 (₹ in Cr.) | Q1FY26 (₹ in Cr.) |
|---|---|---|
| Revenue from operations | 1,022 | 957 |
| Total income | 1,035 | 969 |
| Total expenses | 869 | 840 |
| EBITDA (₹ in Cr.) | 184 | 150 |
| EBITDA Margin (%) | 18.00 | 15.67 |
| Profit before tax | 168 | 129 |
| Net profit | 125 | 95 |
| Basic and diluted EPS (₹) | 6.43 | 4.89 |
Segment Performance and Market Dynamics
The Crop Care business reported revenue of ₹697 crore, registering a 7% year-on-year growth. Domestic (B2C) revenue reached ₹534 crore from ₹449 crore, fueled by a 15% volume growth, partially offset by a 19% decline in the B2B segment. The Soil & Plant Health (SPH) segment delivered 10% growth to ₹62 crore, driven by prudent pricing actions. The Seeds business reported revenue of ₹325 crore, growing 6% year-on-year, primarily due to a 6% price increase as volume declined in cotton. Managing Director Dr. Gyanendra Shukla noted that while cotton acreage declined significantly, growth in rice, maize, and millet segments offset the impact. Exports de-grew by 28% to ₹110 crore due to lower demand for pendimethalin in Europe and competitive pricing from China. Conversely, Contract Sales Manufacturing (CSM) revenue surged 191% to ₹24 crore.
Strategic Initiatives and Outlook
Q1FY27 was characterized by a weak demand environment and sustained pricing pressure in the Indian agrochemical space. Supply chain fragility and dependence on Chinese inputs influenced sourcing dynamics. The delayed onset of the South-West monsoon weighed on on-ground consumption, with cumulative rainfall deficit below normal as of early July. However, sowing activity accelerated by mid-July, reaching ~32% of the normal area. The company launched four new crop care products, including Balwan and Prodim Ultra, and two new cotton hybrids for North India. Digital marketing interventions via Anubandh Edge and Sampark+ continued to enhance farmer outreach. CFO Bhaskar Swaminathan clarified that a ₹35 crore reversal of provisions for performance incentives included ₹24 crore of one-time corrections, while ₹11 crore relates to recurring annual settlements. The company maintains a healthy cash and liquid balance of ₹309 crore as of June 30, 2026.
Historical Stock Returns for Rallis
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.29% | -1.51% | -5.40% | -24.12% | -42.76% | -24.97% |
How might the sustained 28% decline in exports, driven by Chinese competition and weak European demand for pendimethalin, impact Rallis India's revenue mix and margin outlook for the remainder of FY27?
Given the significant drop in cotton acreage and volume, will the company's strategic push into rice, maize, and millet segments be sufficient to offset long-term growth headwinds in its core Seeds business?
With raw material costs rising sharply (₹618 crore vs ₹473 crore) and continued dependence on Chinese inputs, what specific hedging or sourcing diversification strategies is Rallis employing to protect EBITDA margins in Q2?


































